CE vs INCY · rev $5.09B vs P/E 14, rev $5.14B
Celanese Corporation (CE) versus Incyte Corporation (INCY) — a side-by-side from cached financials, not a winner call.
Celanese Corporation (CE) is a chemicals company listed on US.
Incyte Corporation (INCY) is a biotechnology company listed on US.
Latest reported CE revenue for 2026-06-30 was $5.09B. Net income was $169.0M. CE currently screens at market cap $5.92B.
Latest reported INCY revenue for 2025-12-31 was $5.14B. Net income was $1.29B. Revenue was up 21.2% from 2024-12-31 to 2025-12-31. INCY currently screens at market cap $20.45B and trailing P/E 14.5.
CE currently screens at market cap $5.92B. INCY currently screens at market cap $20.45B and trailing P/E 14.5.
Not investment advice. Open the CE and INCY stock pages for the full models.
Not investment advice.